featured
-

How NOT to write a news article about a clinical trial
A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!
-

Huntington's Disease Therapeutics Conference 2016 – day 3
Stem cells and modeling Huntington's disease in our final Therapeutics Conference report
-

Huge study reveals new 'genetic modifiers' of Huntington's disease
GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset
-

Switching it up: variety in the HD gene affects symptom onset
Variety in the HD gene’s on switch affects when symptoms arise.
-

Positive results announced for re-worked tetrabenazine drug in Huntington's disease
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
-

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
By Dr Leora Fox -

EuroBuzz 2014: day three
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona


